What Imperagen does
Imperagen runs a closed-loop, AI-guided enzyme engineering platform for designing improved, production-ready enzymes. It combines physics-based computational modeling with experimental validation in a feedback loop, aiming to deliver tested enzyme variants rather than predictions alone for commercial biotechnology applications.
Key capabilities
The platform integrates problem-specific AI modeling that uses quantum mechanics and physics-based simulation to screen large numbers of potential mutations in silico, high-throughput laboratory testing that builds and evaluates many variants per cycle, and a feedback loop where experimental results retrain the AI model to compound improvements across iterations. Projects typically complete in a few months over a small number of optimization rounds, and the approach is enzyme-agnostic, applicable to classes such as oxidases, reductases, and transaminases.
Who it's for
Imperagen serves biopharma and drug development, molecular diagnostics, chemical manufacturing, and pharmaceutical API production. Its differentiation is experimentally validated, production-ready enzyme designs delivered through a closed-loop AI-and-lab process that reduces R&D cycles and time to commercialization.